Seelos Therapeutics Inc

CUSIP: 81577f109 Class: COM

HOLLENCREST CAPITAL MANAGEMENT's Holding History (CIK: 0001161722)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 22,600 Value ($000) $54 Avg Close — Range —
Q2 2021
Shares 23,600 Value ($000) $63 Avg Close — Range —
Q1 2021
Shares 23,000 Value ($000) $115 Avg Close — Range —